What does CUSIP 30233G100 represent in this 13F holders report?

CUSIP 30233G100 is the security identifier for EYPT - EYEPOINT PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held EYPT - EYEPOINT PHARMACEUTICALS INC - COM in Q3 2018?

33 institutional investors reported EYPT - EYEPOINT PHARMACEUTICALS INC - COM for Q3 2018. Use the holders table for investor-level position and value details.

EYEPOINT PHARMACEUTICALS INC - COM (EYPT)

CUSIP: 30233G100

Q3 2018 13F Holders as of 30 Sep 2018

Security type / class: Equity / COM
Total 13F shares: 7,518,157
Total 13F value: $26,843,000
Share change: -1,056,693
Put/Call ratio: 99%
SEC-reported price per share: $3.57
Number of holders: 33
Value change: -$1,982,762
Number of buys: 14
Number of sells: 19

Security key

30233G100

Report period

Q3 2018

Institutions

Top holders

EYPT full security history Ownership snapshot Full 13F holder table EyePoint, Inc. SEC filings EyePoint, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of EYPT - EYEPOINT PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

HighTower Advisors, LLC

Disclosed value leader

HighTower Advisors, LLC

Comparable rows

0/15

Latest evidence

30 Jun 2018

13F Highest disclosed value: $5,628,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

HighTower Advisors, LLC has the largest disclosed position value at $5.63M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HighTower Advisors, LLC's linked filing trail.

Disclosed position value Top 5

HighTower Advisors, LLC $5.63M

VANGUARD GROUP INC $3.64M

RENAISSANCE TECHNOLOGIES LLC $2.34M

Orbis Allan Gray Ltd $1.43M

JPMORGAN CHASE & CO $781K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
HighTower Advisors, LLC	13F Company 13F	— denominator unverified	$5,628,000 2,705,644 shares	—	30 Jun 2018
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$3,643,000 1,751,347 shares	—	30 Jun 2018
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$2,339,000 1,124,300 shares	—	30 Jun 2018
Orbis Allan Gray Ltd	13F Company 13F	— denominator unverified	$1,433,000 774,533 shares	—	30 Jun 2018
JPMORGAN CHASE & CO	13F Company 13F	— denominator unverified	$781,000 375,505 shares	—	30 Jun 2018
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$590,000 283,854 shares	—	30 Jun 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

7,518,157

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

Q3 2018 holders

Holder diff

-1

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 value	Q3 2018 value	Value change	Value Chg %